HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Maria Luisa García Selected Research

dexibuprofen

10/2017Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways.
1/2017New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Maria Luisa García Research Topics

Disease

9Alzheimer Disease (Alzheimer's Disease)
04/2021 - 01/2017
2Obesity
06/2020 - 09/2018
2Inflammation (Inflammations)
04/2020 - 03/2018
2Neuroinflammatory Diseases
04/2020 - 10/2019
2Insulin Resistance
04/2020 - 08/2019
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2019 - 08/2019
2Diabetes Mellitus
10/2019 - 08/2019
2Type 2 Diabetes Mellitus (MODY)
10/2019 - 08/2019
2Cognitive Dysfunction
09/2018 - 10/2017
2Amyloid Plaque
03/2018 - 01/2017
1Infections
11/2021
1Acne Vulgaris
11/2021
1Disease Progression
04/2021
1Huntington Disease (Huntington's Disease)
01/2021
1Memory Disorders (Memory Loss)
04/2020
1Hyperglycemia
10/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
08/2019
1Dementia (Dementias)
01/2019
1Sleep Initiation and Maintenance Disorders (Insomnia)
01/2019
1Glaucoma
01/2018
1Temporal Lobe Epilepsy
01/2018
1Ocular Hypertension (Glaucoma, Suspect)
01/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018
1Encephalitis (Encephalitis, Rasmussen)
01/2017
1Angioedema
06/2008
1Urticaria (Hives)
06/2008
1Vomiting
06/2008
1Diarrhea
06/2008
1Anaphylaxis (Anaphylactic Shock)
06/2008
1Dyspnea (Shortness of Breath)
06/2008

Drug/Important Bio-Agent (IBA)

4Memantine (Namenda)FDA Link
06/2020 - 01/2018
4Pharmaceutical PreparationsIBA
10/2019 - 01/2017
3epigallocatechin gallate (epigallocatechin-3-gallate)IBA
01/2021 - 01/2018
3Insulin (Novolin)FDA Link
04/2020 - 08/2019
2Biomarkers (Surrogate Marker)IBA
04/2021 - 01/2019
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2020 - 10/2017
2Ophthalmic Solutions (Eye Drops)IBA
04/2020 - 01/2018
2SugarsIBA
10/2019 - 08/2019
2Amyloid (Amyloid Fibrils)IBA
10/2019 - 09/2018
2dexibuprofenIBA
10/2017 - 01/2017
1ThymolIBA
11/2021
1Anti-Bacterial Agents (Antibiotics)IBA
11/2021
1AntioxidantsIBA
11/2021
1Ibuprofen (Motrin)FDA LinkGeneric
04/2020
1Toll-Like Receptor 4IBA
04/2020
1Proteins (Proteins, Gene)FDA Link
10/2019
1CarbohydratesIBA
10/2019
1FlavonoidsIBA
10/2019
1Volatile Oils (Essential Oils)IBA
10/2019
1Peptides (Polypeptides)IBA
10/2019
1SynaptophysinIBA
10/2019
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
10/2019
1BenzodiazepinesIBA
01/2019
1MelatoninIBA
01/2019
1polyethylene glycol-poly(lactide-co-glycolide)IBA
03/2018
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2018
1N-Methylaspartate (NMDA)IBA
01/2018
1Glutamic Acid (Glutamate)FDA Link
01/2018
1AntigensIBA
06/2008
1AllergensIBA
06/2008

Therapy/Procedure

1Glycemic Control
10/2019
1Oral Administration
03/2018
1Therapeutics
01/2018
1Nanospheres
01/2017